| 1 (28) | Hoffmann-La Roche Ltd, United States | USA |  |
| 2 (34) | Merck & Co Inc, United States | USA | |
| 3 (40) | Genentech Inc | USA | |
| 4 (42) | Pfizer Inc, United States | USA | |
| 5 (67) | IBM United States | USA | |
| 6 (110) | Bristol-Myers Squibb Company, United States | USA | |
| 7 (115) | GlaxoSmithKline, United States | USA | |
| 8 (120) | Regeneron Pharmaceuticals Inc | USA | |
| 9 (142) | Eli Lilly and Company, United States | USA | |
| 10 (160) | Novartis Institutes for Biomedical Research, United States | USA | |
| 10 (160) | Hoffmann-La Roche, GmbH., Germany | DEU | |
| 12 (167) | AstraZeneca, United States | USA | |
| 13 (173) | AstraZeneca, United Kingdom | GBR | |
| 14 (187) | Novartis Institutes for Biomedical Research, Switzerland | CHE | |
| 15 (207) | Janssen Biotech Inc | USA | |
| 16 (210) | Celgene Corp | USA | |
| 17 (211) | Hoffmann-La Roche Ltd, Switzerland | CHE | |
| 18 (212) | Bayer AG, Germany | DEU | |
| 19 (218) | Amgen, USA | USA | |
| 20 (222) | GlaxoSmithKline, United Kingdom | GBR | |
| 21 (229) | MedImmune, LLC. | USA | |
| 22 (240) | AstraZeneca, Sweden | SWE | |
| 23 (243) | Takeda Pharmaceuticals International Inc, USA | USA | |
| 24 (250) | AbbVie Inc, United States | USA | |
| 25 (259) | Gilead Sciences Inc, United States | USA | |
| 26 (309) | Takeda Pharmaceutical Co Inc, Japan | JPN | |
| 27 (310) | Janssen Research & Development, LLC | BEL | |
| 28 (324) | Sanofi, United States | USA | |
| 29 (352) | Biogen Idec, USA | USA | |
| 30 (364) | Merck KGaA, Germany | DEU | |
| 31 (426) | Allergan plc, USA | USA | |
| 31 (426) | Astellas Pharma Inc | JPN | |
| 33 (445) | Novo Nordisk A/S | DNK | |
| 34 (450) | Unilever, United Kingdom | GBR | |
| 35 (462) | BASF, Germany | DEU | |
| 36 (471) | GlaxoSmithKline, Belgium | BEL | |
| 37 (472) | Novartis, Switzerland | CHE | |
| 38 (480) | Boehringer Ingelheim GmbH Germany | DEU | |
| 39 (484) | Daiichi Sankyo Co., Ltd. Japan | JPN | |
| 40 (496) | Eli Lilly and Company Ltd., United Kingdom | GBR | |
| 41 (538) | RTI Health Solutions | USA | |
| 42 (542) | Novartis Pharmaceuticals, United States | USA | |
| 43 (546) | Pfizer Inc, United Kingdom | GBR | |
| 44 (564) | Procter & Gamble, USA | USA | |
| 45 (568) | Translational Research Institute | AUS | |
| 46 (580) | Boehringer Ingelheim, USA | USA | |
| 46 (580) | Shionogi & Co Ltd | JPN | |
| 48 (594) | Bayer Corp, USA | USA | |
| 49 (621) | UCB Pharma SA, Brussels | BEL | |
| 50 (704) | Dow Chemical Co USA | USA | |
| 51 (719) | Syngenta, United Kingdom | GBR | |
| 52 (867) | Pharmaceutical Product Development LLC | USA | |
| 53 (868) | Johnson & Johnson, United States | USA | |
| 54 (886) | Nestle Switzerland | CHE | |
| 55 (911) | Corteva, USA | USA | |
| 56 (1006) | EMMES Corp | USA | |
|
